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[General Methods] 
All reactions were carried out under a positive pressure of argon. For column chromatography, silica 
gel (KANTO KAGAKU N-60) was employed. All melting points are uncorrected. Exact mass 
spectra were recorded on Waters MICROMASS® LCT PREMIERTM or Bruker Esquire200T. NMR 
spectra were recorded using a JEOL GSX400 spectrometer at 400 MHz frequency for 1H and 100 
MHz frequency for 13C in CDCl3. Chemical shifts are calibrated to the solvent signal. For HPLC 
separations, a Cosmosil 5C18-AR-II analytical column (Nacalai Tesque, 4.6 x 250 mm, flow rate 1 
mL/min), a 5C18-AR-II semi-preparative column (Nacalai Tesque, 10 x 250 mm, flow rate 2.5 
mL/min) or a 5C18-AR-II preparative column (Nacalai Tesque, 20 x 250 mm, flow rate 10 mL/min) 
was employed, and eluting products were detected by UV at 220 nm. A solvent system consisting of 
0.1% TFA solution (v/v, solvent A) and 0.1% TFA in MeCN (v/v, solvent B) was used for HPLC 
elution. Elemental analysis was performed with Yanaco MT-3 CHN-Corder. Melting point was 
uncorrected. Photolysis was performed using Moritex MUV-202U with the filtered output (>365 nm) 
of a 3000 mW/cm2 Hg-Xe lamp. The confocal microscopic cell images were observed with LSM510, 
Zeiss, Oberkochen, Germany. All chemicals were purchased from either Kanto Chemicals, Sigma 
Aldrich Japan, Tokyo Chemical Industry Kogyo, Wako Pure Chemical Industries or Watanabe 
Chemical Industry. 
 
[Preparation of Photo-responsive Processing Device 7] 
3-(2-Benzyloxy-4,6-dimethylphenyl)-2-(1,2-di-tert-butoxycarbonylhydrazinyl)-3,3-dimethylpro
panal (S1).  
OBn
CHON
BocHN
Boc
 
To a solution of aldehyde 2[S1] (5.25 g, 17.7 mmol) in dichloromethane (106 mL) were added 
di-tert-butyl azodicarboxylate (4.49 g, 19.5 mmol) and pyrrolidine (0.740 mL, 8.87 mmol), and the 
resulting solution was stirred for 24 h. After addition of saturated aqueous solution of NH4Cl, the 
resulting solution was stirred for 30 min and then extracted with diethyl ether. Obtained organic 
phase was washed with brine, dried over Na2SO4, and concentrated in vacuo to give a crude product, 
which was purified by column chromatography (SiO2, hexane/AcOEt = 20/1 then 10/1) and 7.89 g 
of alcohol S1 (15.0 mmol, 85%) was obtained as a white amorphousness: 1H NMR (CDCl3, 400 
MHz) δ = 1.14-1.26 (18H), 1.62-1.80 (6H), 2.18-2.23 (3H), 2.51-2.60 (3H), 5.00-5.41 (3H), 
6.43-6.65 (2H), 7.28-7.45 (5H), 9.40-9.80 (1H); HRMS (ESI-TOF) calc. for C30H43N2O6 ([M + H]+): 
527.3121, found: 527.3114. 
 
 S3 
3-(2-Benzyloxy-4,6-dimethylphenyl)-2-(1,2-di-tert-butoxycarbonylhydrazinyl)-3,3-dimethylpro
panol (S2). 
OBn
N
BocHN
Boc
OH
 
To a stirred solution of aldehyde S1 (7.89 g, 15.0 mmol) in methanol (182 mL) was added sodium 
borohydride (0.681 g, 18.0 mmol) at 0 °C, and the resulting suspension was stirred at room 
temperature for 30 min. After addition of saturated aqueous solution of NH4Cl, the reaction mixture 
was stirred for 30 min and then extracted with AcOEt. The combined organic layer was washed with 
brine, dried over Na2SO4 and concentrated in vacuo. The crude product was purified by 
reprecipitation from hexane and 7.93 g of diBoc alcohol S2 (15.0 mmol, quant) was obtained as 
white powder: 1H NMR (CDCl3, 400 MHz) δ = 1.18-1.24 (9H), 1.40-1.43 (9H), 1.50-1.59 (6H), 
2.19-2.23 (3H), 2.49-2.60 (3H), 3.60-3.79 (2H), 4.20-4.25 and 4.587-4.70 (1H), 4.86-5.15 (2H), 
6.40-6.70 (2H), 7.30-7.50 (5H); HRMS (ESI-TOF) calc. for C30H44N2NaO6 ([M + Na]+): 551.3097, 
found: 551.3113; Anal. Calc. for C30H44N2O6: C, 68.15; H, 8.39; N, 5.30. Found: C, 67.93; H, 8.57; 
N, 5.26. 
 
3-(2-Benzyloxy-4,6-dimethylphenyl)-2-(1,2-di-tert-butoxycarbonylhydrazinyl)-3,3-dimethylpro
panol tert-butyldimethylsilyl ether (3).  
OBn
N
BocHN
Boc
OTBS
 
Triethylamine (6.16 mL, 44.2 mmol) and tert-butyldimethylsilyl trifluoromethanesulfonate (5.67 mL, 
24.7 mmol) were added to a solution of alcohol S2 (9.00 g, 17.0 mmol) in dichloromethane (100 
mL) at 0 °C. The resulting mixture was stirred for 1 h and was quenched by the addition of water. 
After being extracted with dichloromethane, combined organic layer was washed with brine, dried 
over Na2SO4, and concentrated in vacuo to give a crude product, which was purified by column 
chromatography (SiO2, chloroform)  and 9.73 g of TBS ether 3 (15.1 mmol, 89%) was obtained as 
pale yellow oil: 1H NMR (CDCl3, 400 MHz) δ = -0.25-0.00 (6H), 0.70-0.90 (9H), 1.16-1.65 (24H), 
2.08-2.18 (3H), 2.40-2.56 (3H), 3.30-3.40 (1H), 3.78-3.85 (1H), 4.90-5.10 (3H), 5.89-6.20 (1H), 
6.40-6.52 (2H), 7.20-7.62 (5H); HRMS (ESI-TOF) calc. for C33H46NaN4O9 ([M + Na]+): 655.3162, 
found: 665.3143. 
 
 
 S4 
3-(2-Benzyloxy-4,6-dimethylphenyl)-2-(1,2-di-tert-butoxycarbonyl-2-trifluoroacetylhydrazinyl)
-3,3-dimethylpropanol tert-buthyldimethylsilyl ether (S3).  
OBn
N
N
Boc
OTBS
Boc
F3C
O
 
To a stirred solution of TBS ether 3 (9.65 g, 15.0 mmol) in dichloromethane (115 mL) were added 
pyridine (12.1 mL, 150 mmol) and trifluoroacetic anhydride (10.4 mL, 75.0 mmol) at 0 °C. After 
being stirred for 4 h, the reaction was quenched by the addition of saturated aqueous solution of 
NH4Cl at 0 °C. The resulting mixture was extracted with AcOEt, and the combined organic layer 
was washed with brine, dried over Na2SO4 and concentrated in vacuo. The obtained 
trifluoroacetamide S3 was unstable and was used without further purification: 1H NMR (CDCl3, 400 
MHz) δ = -0.15-0.02 (6H), 0.86-0.98 (9H), 1.10-1.65 (24H), 2.06-2.12 (3H), 2.13-2.122 (3H), 
3.20-4.32 (2H), 4.57-5.18 (3H), 6.50-6.62 (2H), 7.26-7.75 (5H); LRMS (ESI-TOF) calc. for 
C38H57N2O7F3NaSi ([M + Na]+): 761.4, found: 761.3. 
 
3-(2-Benzyloxy-4,6-dimethylphenyl)-2-tert-butoxycarbonylamino-3,3-dimethylpropanol 
tert-buthyldimethylsilyl ether (4).  
OBn
BocHN
OTBS
 
Trifluoroacetamide S3 (0.500 g, 0.640 mmol) in THF (1.29 mL) was treated with 0.1 M SmI2 in 
THF (55.5 mL. It was prepared from Sm and CH2I2 in THF[S2]) - hexamethylphosphoramide (1.98 
mL) in the presence of tert-BuOH (1.29 mL) for 3 h. The resulting mixture was quenched by the 
addition of saturated aqueous solution of NH4Cl and was extracted with diethyl ether. The combined 
organic layer was washed with brine, dried over MgSO4 and concentrated in vacuo. The crude 
product was purified by column chromatography (SiO2, hexane/AcOEt = 40/1) and 0.250 g of Boc 
TBS ether 4 (0.470 mmol, 74%) was obtained as a pale yellow oil: 1H NMR (CDCl3, 400 MHz) δ = 
-0.04 (3H, s), -0.03 (3H, s), 0.92 (9H, s), 1.41 (9H, s), 1.48 (3H, s), 1.48 (3H, s), 2.22 (3H, s), 2.56 
(3H, s), 3.49 (1H, dd, J = 10.0 and 5.2 Hz), 3.57 (1H, dd, J = 10.0 and 5.2 Hz), 4.59 (1H, dt, J = 9.0 
and 5.2 Hz), 4.87 (1H, d, J = 9.0 Hz), 5.07 (1H, d, J = 12.0 Hz), 5.13 (1H, d, J = 12.0 Hz), 6.56 (1H, 
s), 6.62 (1H, s), 7.30 (1H, t, J = 8.0 Hz), 7.37 (2H, t, J = 8.0 Hz), 7.48 (2H, d, J = 8.0 Hz); 13C NMR 
(CDCl3, 75 MHz) δ = -5.6 (CH3), -5.5 (CH3), 18.1 (C), 20.8 (CH3), 25.9 (CH3 x 3), 25.9 (CH3 x 3), 
27.7 (CH3), 28.4 (CH3), 29.3 (CH3), 44.6 (C), 56.6 (CH), 63.7 (CH2), 63.7 (C), 71.0 (CH2), 112.7 
(CH), 127.3 (CH x 4), 127.6 (CH), 128.5 (CH), 128.5 (C), 131.3 (C), 136.1 (C), 137.5 (C), 138.6 (C), 
 S5 
158.7 (C); HRMS (ESI-TOF) calc. for C31H49NO4 NaSi([M + Na]+): 550.3329, found: 550.3326. 
 
2-tert-Butoxycarbonylamino-3,3-dimethyl-3-(4,6-dimethyl-2-hydroxyphenyl)propanol 
tert-buthyldimethylsilyl ether (S4).  
OH
BocHN
OTBS
 
To a solution of benzyl ether 4 (3.37 g, 6.38 mmol) in methanol (32.9 mL) was added palladium on 
carbon (10%, 1.01 g), and the obtained mixture was stirred under H2 for 24 h. Resulting suspension 
was filtered through the Celite, and the filtrate was concentrated in vacuo. Obtained residue was 
purified by column chromatography (SiO2, hexane/AcOEt = 20/1 then 10/1) and 2.05 g of phenol S4 
(4.67 mmol, 73%) was obtained as a white amorphousness: 1H NMR (CDCl3, 400 MHz) δ = -0.06 
(3H, s), -0.04 (3H, s), 0.85 (9H, s), 1.48 (9H, s), 1.52 (3H, s), 1.54 (3H, s), 2.15 (3H, s), 2.47 (3H, s), 
3.51 (2H, d, J = 4.6 Hz), 4.83 (1H, br s), 5.06 (1H, br s), 6.43 (1H, s), 6.59 (1H, s), 7.56 (1H, br s); 
13C NMR (CDCl3, 100 MHz) δ = -3.7 (CH3), -3.5 (CH3), 20.1 (C), 22.2 (CH3 x 2), 27.8 (CH3 x 3), 
28.5 (CH3), 30.3 (CH3), 30.5 (CH3 x 3), 47.0 (C), 57.0 (CH), 66.0 (CH2), 81.2 (C), 118.0 (CH), 
127.8 (C), 129.6 (CH), 137.7 (C), 139.5 (C), 158.6 (C), 158.6 (C); HRMS (ESI-TOF) calc. for 
C24H43NNaO4Si ([M + Na]+): 460.2859, found: 460.2859. 
 
2-tert-Butoxycarbonylamino-3,3-dimethyl-3-(2,4-dimethyl-6-(2-nitrobenzyloxy)phenyl)propano
l tert-buthyldimethylsilyl ether (5).  
O
BocHN
OTBS
NO2
 
To a stirred solution of phenol S4 (2.05 g, 4.67 mmol) in DMF (20.5 mL) were added K2CO3 (1.16 g, 
8.41 mmol) and o-nitrobenzyl bromide (2.02 g, 9.35 mmol), and the resulting suspension was stirred 
for 24 h. After being added an aqueous ammonium hydroxide, the reaction mixture was stirred for 30 
min, added H2O and extracted with diethyl ether. Organic phase was washed with H2O (x2) and 
brine, dried over MgSO4 and concentrated in vacuo. The crude product was purified by column 
chromatography (SiO2, hexane/AcOEt = 20/1) and 2.41 g of ether 5 (4.21 mmol, 90%) was obtained 
as a pale yellow oil: 1H NMR (CDCl3, 400 MHz) δ = -0.03 (3H, s), -0.02 (3H, s), 0.87 (9H, s), 1.44 
(9H, s), 1.55 (3H, s), 1.59 (3H, s), 2.21 (3H, s), 2.57 (3H, s), 3.55 (1H, dd, J = 10.4 and 3.6 Hz), 3.60 
(1H, dd, J = 10.4 and 3.6 Hz), 4.73 (1H, dt, J = 10.0 and 3.6 Hz), 4.91 (1H, d, J = 10.0 Hz), 5.49 (1H, 
 S6 
d, J = 16.0 Hz), 5.60 (1H, d, J = 16.0 Hz), 6.56 (1H, s), 6.61 (1H, s), 7.48 (1H, t, J = 7.5 Hz), 7.73 
(1H, t, J = 7.5 Hz), 8.16 (1H, d, J = 7.5 Hz), 8.19 (1H, d, J = 7.5 Hz); 13C NMR (CDCl3, 100 MHz) δ 
= -3.4 (CH3), -3.5 (CH3), 20.1 (C), 22.6 (CH3), 27.8 (CH3 x 3), 27.9 (CH3), 29.3 (CH3), 30.4 (CH3 x 
3), 31.0 (CH3), 47.0 (C), 57.9 (CH), 65.7 (CH2), 70.7 (CH2), 80.4 (CH2), 115.2 (CH), 126.7 (CH), 
129.8 (CH), 130.1 (CH), 131.2 (CH), 133.1 (C), 136.3 (CH), 138.2 (C), 140.5 (C), 148.2 (C), 157.8 
(C), 160.0 (C); HRMS (ESI-TOF) calc. for C31H48N2NaO6Si ([M + Na]+): 595.3179, found: 
595.3177. 
 
2-tert-Butoxycarbonylamino-3,3-dimethyl-3-(2,4-dimethyl-6-(2-nitrobenzylox)phenyl)propanol 
(S5). 
O
BocHN
OH
NO2
 
Glacial acetic acid (31.6 mL) and water (10.5 mL) were added to a solution of silyl ether 5 (2.41 g, 
4.21 mmol) in THF (10.5 mL). The reaction mixture was stirred for overnight and was quenched by 
the addition of water. After being extracted with AcOEt, organic phase was washed with saturated 
aqueous solution of NaHCO3 and brine, dried over Na2SO4 and concentrated in vacuo. The crude 
product was purified by column chromatography (SiO2, hexane/AcOEt = 5/1 then 2/1) and 1.45 g of 
alcohol S5 (3.16 mmol, 75%) was obtained as a white amorphousness: 1H NMR (CDCl3, 400 MHz) 
δ = 1.40 (9H, s), 1.53 (3H, s), 1.55 (3H, s), 2.19 (3H, s), 2.54 (3H, s), 3.54 (1H, dd, J = 10.0 and 8.6 
Hz), 3.68 (1H, d, J = 10.0 Hz), 4.67 (1H, t, J = 8.6 Hz), 4.91 (1H, d, J = 8.6 Hz), 5.50 (1H, d, J = 
16.0 Hz), 5.58 (1H, d, J = 16.0 Hz), 6.52 (1H, s), 6.61 (1H, s), 7.50 (1H, t, J = 7.6 Hz), 7.70 (1H, t, J 
= 7.6 Hz), 7.93 (1H, d, J = 7.6 Hz), 8.19 (1H, d, J = 7.6 Hz); 13C NMR (CDCl3, 100 MHz) δ = 20.6 
(CH3), 25.9 (CH3), 27.4 (CH3), 28.3 (CH3 x 3), 28.5 (CH3), 43.9 (C), 58.4 (CH), 63.7 (CH2), 68.9 
(CH2), 79.0 (C), 113.5 (CH), 124.8 (CH), 128.0 (CH), 128.3 (CH), 129.0 (CH), 130.5 (C), 134.1 
(CH), 136.4 (C), 138.0 (C), 146.3 (C), 1568 (C), 158.1 (C); HRMS (ESI-TOF) calc. for 
C25H34N2NaO6 ([M + Na]+): 481.2315, found: 481.2312. 
 
 
 
 
 
 
 
 S7 
2-tert-Butoxycarbonylamino-3,3-dimethyl-3-(2,4-dimethyl-6-(2-nitrobenzyloxy)phenyl)propana
l (S6).  
O
CHOBocHN
NO2
 
To a stirred solution of alcohol S5 (1.45 g, 3.16 mmol) in dichloromethane (31.6 mL) was added 
PCC (2.73 g, 12.6 mmol), and resulting suspension was stirred for overnight. Reaction mixture was 
directly loaded on silica gel column chromatography (SiO2, hexane/AcOEt = 1/0 then 5/1) and 1.13 
g of aldehyde S6 (2.48 mmol, 79%) was obtained as white amorphousness: 1H NMR (CDCl3, 400 
MHz)  δ = 1.41 (9H, s), 1.50 (3H, s), 1.62 (3H, s), 2.21 (3H, s), 2.52 (3H, s), 5.18 (1H, br d, J = 11.2 
Hz), 5.42 (1H, d, J = 11.2 Hz), 5.54 (1H, d, J = 21.0 Hz), 5.62 (1H, d, J = 21.0 Hz), 6.57 (1H, s), 
6.64 (1H, s), 7.50 (1H, t, J = 10.0 Hz), 7.70 (1H, td, J = 10.0 and 1.2 Hz), 7.94 (1H, br d, J = 10.0 
Hz), 8.20 (1H, dd, J = 10.0 and 1.2 Hz), 9.48 (1H, s); 13C NMR (CDCl3, 100 MHz) δ = 20.7 (CH3), 
25.9 (CH3), 27.4 (CH3), 28.2 (CH3 x 3), 28.3 (CH3), 44.0 (C), 65.5 (CH), 68.8 (CH2), 79.5 (C), 113.5 
(CH), 125.1 (C), 128.4 (CH), 128.7 (CH), 129.3 (C), 129.4 (C), 133.9 (C), 134.3 (CH), 134.3 (CH), 
137.5 (C) 138.2 (C), 155.9 (C), 158.0 (C), 201.4 (CH); HRMS (ESI-TOF) calc. for C25H32N2NaO6 
([M + Na]+): 479.2158, found: 479.2145. 
 
3,3-Dimethyl-3-(2,4-dimethyl-6-(2-nitrobenzyloxy)phenyl)-2-(9-fluorenylmethylcarbonylamino
) propionic acid (7).  
O
CO2HFmocHN
NO2
 
2-Methyl-2-butene (1.77 mL, 16.7 mmol), NaH2PO4 (0.446 g, 3.72 mmol) and NaClO2 (1.30 g, 14.4 
mmol) were added to a solution of aldehyde S6 (1.13 g, 2.48 mmol) in acetone/tert-BuOH/H2O 
(6/4/1, 85.3 mL), and the resulting mixture was stirred for overnight. The reaction mixture was 
poured into saturated aqueous solution of NH4Cl and extracted with diethyl ether. Organic phase was 
dried over Na2SO4 and concentrated in vacuo. Hydrogen chloride in AcOEt (4 M, 27.0 mL) was 
added to the crude product 6, and the resulting mixture was stirred for 1.5 h. After being 
concentrated in vacuo, obtained residue was dissolved in acetonitrile/10% aqueous solution of 
Na2CO3 (1/1, 22.4 mL). To the resulting solution was added FmocOSu (0.878 g, 2.60 mmol), and the 
reaction mixture was stirred for 3 h. After being acidified by 5% aqueous solution of KHSO4, 
 S8 
obtained mixture was extracted with diethyl ether. The organic phase was washed with brine and 
concentrated in vacuo. Obtained crude product was purified by column chromatography (SiO2, 
chloroform/MeOH = 1/0 then 200/1) and 1.47 g of Fmoc derivative 7 (2.47 mmol, quant) was 
obtained as pale yellow amorphousness: 1H NMR (CDCl3, 400 MHz) δ =1.67 (3H, s), 1.71 (3H, s), 
2.16 (3H, s), 2.54 (3H, s), 4.15 (1H, t, J = 8.4 Hz), 4.24 (1H, t, J = 8.4 Hz), 4.39 (1H, t, J = 8.4 Hz), 
5.48-5.70 (4H, m), 6.52 (1H, s), 6.59 (1H, s), 7.30 (2H, d, J = 7.2 Hz), 7.36-7.48 (3H, m), 7.50 (1H, 
d, J = 7.2 Hz), 7.56 (1H, d, J = 7.2 Hz), 7.62 (1H, t, J = 7.6 Hz), 7.77 (2H, d, J = 7.2 Hz), 7.97 (1H, 
d, J = 7.6 Hz), 8.18 (1H, d, J = 8.0 Hz), 10.60 (1H, br s); 13C NMR (CDCl3, 100 MHz) δ = 20.7 
(CH3), 25.7 (CH3), 27.7 (CH3), 28.3 (CH3), 44.4 (C), 47.0 (CH), 59.5 (CH), 66.9 (CH2), 68.7 (CH2), 
113.1 (CH), 119.7 (CH x 2), 124.8 (CH x 2), 126.8 (CH), 126.8 (CH), 127.4 (CH x 2), 128.0 (CH x 
2), 128.2 (C), 128.5 (CH), 128.8 (CH), 134.1 (CH), 136.9 (C), 137.8 (C), 141.0 (C x 2), 143.6 (C x 
2), 146.4 (C), 155.8 (C), 158.0 (C), 176.9 (C); HRMS (ESI-TOF) calc. for C35H34N2NaO7 ([M + 
Na]+): 617.2264, found: 617.2266. 
 
[Preparation of Photo-responsive Model Peptides 8] 
Peptide resin (S7).  
H Y(t-Bu)GGFL
 
Fmoc-Leu-OH (0.14 g, 0.40 mmol) was coupled to Nova Syn TGR resin (loading: 0.25 mmol/g, 
0.40 g, 0.10 mmol) in DMF/DMSO = 3/1[S3] at room temperature for 1 h in the presence of DIC (62 
µL, 0.40 mmol) and HOBt·H2O (61 mg, 0.40 mmol). After deprotection of Fmoc group by the 
treatment with 20% piperidine in DMF, peptide elongation was performed by Fmoc chemistry (4.0 
equiv of each amino acid) using DIC (62 µL, 4.0 eq.) / HOBt·H2O (61 mg, 4.0 eq.) in DMF/DMSO 
= 3/1 to give the peptide resin S7. 
 
Coupling of Fmoc derivative 7 with peptide resin S7.  
Y(t-Bu)GGFLFmocHN
O
O
NO2
 
Fmoc derivative 7 (0.12 g, 0.20 mmol) was attached to the amino group of the resin S7 by DIC (31 
µL, 0.20 mmol) and HOBt·H2O (31 mg, 0.20 mmol) in DMF/DMSO = 3/1 for 24 h to give the S8. 
 
 
 
 S9 
Synthesis of photoresponsive peptide 8.  
YGGFL-NH2
H
N
O
O
NO2
YGGFLH
 
Elongation of peptide on S8 (0.20 mmol) was performed as described for peptide resin S7. The 
protected peptide resin was treated with TFA-Et3SiH-H2O (95:2.5:2.5 (v/v), 8.0 mL) at room 
temperature for 1.5 h. After the resin was filtrated off, cooled diethyl ether was added to the filtrate, 
and the resulting precipitate was collected by centrifugation. The obtained precipitate was washed 
with diethyl eshter and purified by RP-HPLC to give the desired photo-responsive peptide 8 (23 mg, 
16%) as a diastereomeric mixture. Analytical HPLC condition: linear gradient of solvent B in 
solvent A, 10 to 60% over 30 min. Retention time = 27.4 or 29.7 min, respectively for each 
diastereomer. Preparative HPLC condition: linear gradient of solvent B in solvent A, 20 to 70% over 
60 min. MS (ESI-TOF, reconstructed) calc. for C76H96N13O16 ([M + H]+): 1446.7, found; 1446.3 and 
1446.2. 
 
[Photo-processing Reaction of Model Peptides 8] 
The photo-responsive peptide 8 (0.50 mg, 0.35 µmol) in acetonitrile (316 µL) was added to 
phosphate buffer (20 mM, pH 7.6, 1.26 mL), and the resulting mixture was irradiated by UV (λ > 
365 nm) for 3 min. The reaction solution was incubated at 37 °C and reaction was monitored by 
analytical HPLC. Analytical HPLC conditions: linear gradient of solvent B in solvent A, 10 to 60% 
over 30 min. 9: retention time = 23.7 or 25.3 min, respectively for each diastereomer, MS (ESI-TOF, 
reconstructed) calc. for C69H91N12O14 ([M + H]+): 1311.7, found 1311.7 and 1311.6; 10: retention 
time = 25.3 or 25.6 min, respectively for each diastereomer, MS (ESI-TOF) calc. for C41H53N6O8 
([M + H]+): 757.4, found 757.1 and 757.1. 11: retention time = 13.7 min, MS (ESI-TOF) calc. for 
C28H39N6O6 ([M + H]+): 555.3, found 555.3. 
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(a)
(b)
(c)
8
8
9
9
11
10
*
*
0 30
tR/min  
Figure S1. HPLC profiles (a) before UV irradiation (b) after 3 min of UV irradiation, and (c) after 3 
min of UV irradiation followed by 2 h of incubation at 37 °C. Peptides were detected by UV 
absorbance at 220 nm. Asterisked peaks are not peptidic compounds. 8, 9, and 10 are diastereomeric 
mixture. 
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[Preparation of Phosphatase-responsive Model Peptide 12] 
OH
BocHN
OTBS
OPO(OMe)2
BocHN
OTBS
CO2H
OPO(OMe)2
BocHN
OPO(OH)2
H
NH-YGGFL GGGFL-NH2
O
i ii, iii, iv
v
S4 S9
S12 12  
Reagents and conditions. (i) dimethyl-N,N-diethylphosphoramidite, 1H-tetrazole, THF, then OXONE, water, 
84%; (ii) AcOH, THF, H2O, 91%; (iii) PCC, CH2Cl2, 79%; (iv) NaClO2, NaH2PO4, tert-BuOH, H2O, acetone, 
2-methyl-2-butene, 63%; (v) Boc SPPS. 
 
2-tert-Butoxycarbonylamino-3,3-dimethyl-3-(2,4-dimethyl-6-dimethoxyphosphoryloxyphenyl)p
ropanol tert-buthyldimethylsilyl ether (S9).  
OPO(OMe)2
BocHN
OTBS
 
To a stirred solution of phenol S4 (0.500 g, 1.14 mmol) in THF (5.00 mL) were added 1H-tetrazole 
(0.340 g, 4.85 mmol) and dimethyl-N,N-diethylphosphoramidite[S4] (0.440 g, 2.66 mmol). After 
being stirred for 4.5 h, OXONE (1.75 g, 2.85 mmol) in water (10.0 mL) was added to the reaction 
mixture at 0 Co. Resulting mixture was stirred for 10 min at same temperature and was extracted 
with AcOEt. Organic phase was washed with saturated aqueous solution of Na2S2O3 and brine, dried 
over Na2SO4 and concentrated in vacuo. The crude product was purified by column chromatography 
(SiO2, hexane/AcOEt = 3/1 then 2/1) and 0.545 g of phosphonate S9 (0.990 mmol, 87%) was 
obtained as a colorless oil: 1H NMR (CDCl3, 400 MHz) δ = -0.05 (3H, s), -0.05 (3H, s), 0.84 (9H, s), 
1.41 (9H, s), 1.48 (3H, s), 1.53 (3H, s), 2.23 (3H, s), 2.58 (3H, s), 3.50 (1H, dd, J = 10.4 and 5.0 Hz), 
3.51 (1H, dd, J = 10.4 and 5.0 Hz), 3.88 (3H, d, J = 11.2 Hz), 3.90 (3H, d, J = 12.0 Hz), 4.42 (1H, dt, 
J = 10.4 and 5.0 Hz), 4.85 (1H, br d, J = 10.4 Hz), 6.75 (1H, s), 7.09 (1H, s); 13C NMR (CDCl3, 100 
MHz) δ = -5.7 (CH3), -5.6 (CH3), 18.0 (C), 20.3 (CH3), 25.6 (CH3), 25.7 (CH3 x 3), 26.9 (CH3), 28.3 
(CH3 x 3), 28.9 (CH3), 44.2 (C), 54.7 (CH3, d, J = 5.8 Hz), 54.8 (CH3, d, J = 5.8 Hz), 56.5 (CH), 
63.4 (CH2), 78.4 (C), 118.3 (CH, d, J = 7.0 Hz), 131.0 (CH), 131.7 (C, d, J = 9.0 Hz), 136.4 (C), 
139.0 (C), 150.2 (C, d, J = 6.0 Hz), 155.8 (C).; HRMS (ESI-TOF) calc. for C26H49NO7PSi ([M + 
H]+): 546.3016, found: 546.3019. 
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2-tert-Butoxycarbonylamino-3,3-dimethyl-3-(2,4-dimethyl-6-dimethylphosphoryloxypropanol 
(S10). 
OPO(OMe)2
BocHN
OH
 
To a solution of silyl ether S9 (0.599 g, 1.10 mmol) in THF (2.70 mL) and H2O (2.70 mL) was added 
glacial acetic acid (8.20 mL). The resulting mixture was stirred for overnight and then quenched by 
the addition of water. After being extracted with AcOEt, organic phase was washed with saturated 
aqueous solution of NaHCO3 and brine, dried over Na2SO4 and concentrated in vacuo. The crude 
product was purified by column chromatography (SiO2, hexane/AcOEt = 1/1 then 1/100) and 0.431 
g of alcohol S10 (1.00 mmol, 91%) was obtained as a colorless oil: 1H NMR (CDCl3, 400 MHz) δ = 
1.42 (9H, s), 1.47 (3H, s), 1.55 (3H, s), 2.24 (3H, s), 2.58 (3H, s), 2.90 (1H, br s), 3.44-3.64 (2H, m), 
3.88 (3H, d, J = 11.6 Hz), 3.89 (3H, d, J = 11.2 Hz), 4.48 (1H, m), 5.04 (1H, d, J = 9.2 Hz), 6.79 (1H, 
s), 7.01 (1H, s); 13C NMR (CDCl3, 100 MHz) δ = 20.3 (CH3), 25.6 (CH3), 26.9 (CH3), 28.3 (CH3 x 
3), 28.7 (CH3), 44.0 (C), 54.9 (CH3, d, J = 9.0 Hz), 55.0 (CH3, d, J = 6.0 Hz), 57.8 (CH), 63.4 (CH2), 
79.1 (C), 119.1 (CH), 131.5 (CH), 131.8 (C, d, J = 7.0 Hz), 136.7 (C), 139.0 (C), 149.9 (C, d, J = 6.0 
Hz), 156.7 (C); HRMS (ESI-TOF) calc. for C20H35NO7P ([M + H]+): 432.2151, found: 432.2145. 
 
2-tert-Butoxycarbonylamino-3,3-dimethyl-3-(2,4-dimethyl-6-dimethoxyphosphoryloxyphenyl)p
ropanal (S11). 
OPO(OMe)2
CHOBocHN
  
Pyridinium chlorochromate (1.10 g, 4.00 mmol) was added to a solution of alcohol S10 (0.431 g, 
1.00 mmol) in dichloromethane (17.2 mL). After being stirred for overnight, resulting mixture was 
directly loaded on silica gel column chromatography (SiO2, hexane/AcOEt = 1/1) and 0.341 g of 
aldehyde S11 (0.790 mmol, 79%) was obtained as white amorphousness: 1H NMR (CDCl3, 400 
MHz)  δ = 1.43 (9H, s), 1.46 (3H, s), 1.56 (3H, s), 2.26 (3H, s), 2.62 (3H, s), 3.87 (3H, d, J = 11.6 
Hz), 3.90 (3H, d, J = 11.2 Hz), 5.15 (1H, d, J = 7.6 Hz), 5.30 (1H, d, J = 7.6 Hz), 6.83 (1H, s), 7.14 
(1H, s), 9.40 (1H, s); 13C NMR (CDCl3, 100 MHz) δ = 20.4 (CH3), 25.5 (CH3), 26.8 (CH3), 28.2 
(CH3 x 3), 29.7 (CH3), 43.3 (C), 54.9  (CH3, d, J = 6.0 Hz), 55.0 (CH3, d, J = 5.0 Hz), 65.3 (CH), 
79.6 (C), 119.0 (CH), 129.3 (C, d, J = 8.0 Hz), 131.5 (CH), 137.6 (C), 138.8 (C), 150.0 (C, d, J = 7.0 
Hz), 155.8 (C), 200.7 (CH); HRMS (ESI-TOF) calc. for C20H33NO7P ([M + H]+): 430.1995, found: 
430.1974. 
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2-tert-Butoxycarbonylamino-3,3-Dimethyl-3-(2,4-dimethyl-6-dimethoxyphosphoryloxyphenyl) 
propionic acid (S12).  
OPO(OMe)2
CO2HBocHN
 
To a solution of aldehyde S11 (0.020 g, 0.047 mmol) in acetone/tert-BuOH/H2O (6/4/1, 1.10 mL) 
were added 2-methyl-2-butene (0.034 mL, 0.32 mmol), NaH2PO4 (0.0085 g, 0.071 mmol) and 
NaClO2 (0.022 g, 0.24 mmol), and the reaction mixture was stirred for 3.5 h. The resulting mixture 
was poured into saturated aqueous solution of NH4Cl and was extracted with diethyl ether. Organic 
phase was dried over Na2SO4 and concentrated in vacuo. Obtained crude product was purified by 
column chromatography (SiO2, hexane/AcOEt = 1/2, then AcOEt) and 0.013 g of carboxylic acid 
S12 (0.030 mmol, 63%) was obtained as colorless oil: 1H NMR (CDCl3, 400 MHz) δ = 1.40 (9H, s), 
1.56 (3H, s), 1.60 (3H, s), 2.24 (3H, s), 2.53 (3H, s), 3.89 (3H, d, J = 11.6 Hz), 3.99 (3H, d, J = 10.0 
Hz), 5.04 (1H, d, J = 9.2 Hz), 5.35 (1H, d, J = 9.2 Hz), 6.79 (1H, s), 6.94 (1H, s); 13C NMR (CDCl3, 
100 MHz) δ = 20.4 (CH3 x 3), 25.4 (CH3), 27.1 (CH3), 28.2 (CH3), 28.3 (CH3), 43.9 (C), 55.1 (CH3, 
d, J = 6.0 Hz), 55.2 (CH3, d, J = 6.0 Hz), 59.0 (CH), 79.5 (C), 118.6 (CH), 130.5 (C, d, J = 6.0 Hz), 
137.0 (CH), 139.2 (C), 150.1 (C), 155.3 (C, d, J = 5.0 Hz), 174.1 (C); HRMS (ESI-TOF) calc. for 
C20H33NO8P ([M + H]+): 446.1934, found: 446.1963. 
 
Peptide resin S13 
. 
H GGGFL  
 
Pre-activated Boc-Leu-OH monohydrate (0.13 g, 0.50 mmol) in the presence of DIC (77 µL, 0.50 
mmol) and HOBt·H2O (76 mg, 0.50 mmol) in DMF (1.0 mL) for 30 min was coupled to MBHA LL 
resin·HCl (loading: 0.70 mmol/g, 0.14 g, 0.10 mmol, pre-washed with 20% piperidine in DMF) for 
3 h. After deprotection of Boc group by 50% TFA with 2% anisole in toluene, peptide elongation 
was performed by Boc chemistry (5.0 equiv of each amino acid) using DIC (77 µL, 0.50 mmol) / 
HOBt·H2O (76 mg, 0.50 mmol.) / DIEA (35 µL, 0.20 mmol) in DMF (1.0 mL) to give the peptide 
resin S13. 
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Coupling of Boc derivative S12 with peptide resin S13. 
GGGFLBocHN
O
OPO(OMe)2
 
Boc derivative S12 (0.25 mmol) was attached to the amino group of the resin S13 by DIC (39 µL, 
0.25 mmol), HOBt·H2O (38 mg, 0.25 mmol) and DIEA (35 µL, 0.20 mmol) in DMF for 40 h to give 
the S14. 
 
Synthesis of phosphate responsive peptide 12. 
GGGFL-NH2
H
N
O
OPO(OH)2
H-YGGFL
 
Elongation of peptide on S14 (0.025 mmol) was performed as described for peptide resin S13. 
Boc-Tyr(2-Br-Z)-OH was used as Tyr building block. For the global deprotection, our two-step 
protocol was used.[S5] To the protected peptide resin (48 mg, 0.016 mmol) were added m-cresol (120 
µL), ethanedithiol (120 µL), and thioanisole (281 µL). After being stirred for 5 min at room 
temperature, reaction mixture was cooled in an ice-chilled bath, and then precooled TFA (1.66 mL) 
and TMSOTf (434 µL) were successively added. After stirring for 1.5 h at 4 °C, dimethylsulfide 
(960 µL) and TMSOTf (240 µL) were added to the reaction mixture. The reaction was carried out 
for 3 h at 4 °C. After filtration of the resin, filtrate was poured into pre-cooled diethyl ether and 
extracted with water. Aqueous phase was washed by cooled diethyl ehter and purified by RP-HPLC 
to give the desired peptide 12 (2.6 mg, 13%) as a diastereomeric mixture. Analytical HPLC 
condition: linear gradient of solvent B in solvent A, 10 to 60% over 30 min. Retention time = 23.6 or 
24.2 min, respectively for each diastereomer. Semi-preparative HPLC condition: linear gradient of 
solvent B in solvent A, 25 to 55% over 30 min. MS (ESI-TOF, reconstructed) calc. for 
C62H86N12O16P ([M + H]+): 1285.6, found; 1285.5 and 1285.6. 
 
[Phosphatase-induced Processing Reaction of Model Peptide 12] 
Alkaline phosphatase solution purchased from Wako Pure Chemical Industries (0.2 µL; 10 units/µL 
alkaline phosphatase, 10 mM Tris-HCl (pH 8.2), 50 mM KCl, 1 mM MgCl2, 0.1 mM ZnCl2, 50% 
glycerol) was added to the peptide 12 (64 µg, 0.050 µmol) in Tris-HCl buffer (88.9 µL; 10 mM 
Tris-HCl (pH 7.9), 50 mM NaCl, 10 mM MgCl2, 1 mM DTT), and the resulting mixture was 
 S15 
incubated at 37 °C for 24 h. Reaction was monitored by analytical HPLC and peptides were 
characterized by ESI-MS. Analytical HPLC condition: linear gradient of solvent B in solvent A, 10 
to 60% over 30 min. 13; Retention time = 12.5 min. MS (ESI-TOF) calc. for C21H33N6O5 ([M + 
H]+): 449.3, found; 449.2. 
 
12
10
13
*
**
(a)
(b)
0 30
tR/min  
Figure S2. HPLC profiles (a) before treatment with alkaline phosphatase and (b) after 24 h of 
incubation with alkaline phosphatase at 37 °C. Peptides were detected by UV absorbance at 220 nm. 
*Non-peptidic compound. **Alkaline phosphatase. 
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[Preparation of Shuttle Peptide 14] 
H2N
i, ii
Boc-RRRRRRRR-KRKRR
H
N
N
H
ALGV-N
HO
OoNB
S15
O
O
NovaSyn
TGR resin
iii, i, iv
Boc-RRRRRRRR-KRKRR
H
N
N
H
ALGV-N
Abu-LARLF-O
OoNB
FTC-
S16
O
O 14
v
H
H
Pbf
Pbf
BocPbf Pbf Pbf Pbf
Pbf
Pbf Pbf Pbf Pbf Pbf
Boc
Pbf
Pbf
BocPbf Pbf Pbf Pbf
Pbf Pbf Pbf Pbf Pbf
Boc
 
Reagents and conditions. (i) Fmoc SPPS; (ii) Boc2O, HOBt, DIEA, DMF; (iii) Fmoc-Phe-Cl, DIEA, DMAP, 
CH2Cl2; (iv) FITC, DIEA, DMF; (v) TFA/triethylsilane/H2O = 95/2.5/2.5. 
 
Peptide elongation. 
Peptide was elongated by Fmoc SPPS in a manner similar to that of photo-responsive model peptide 
8. As a serine building block, side chain unprotected one was used. 
 
Boc protection of N-terminal amine group. 
Peptide resin (0.0375 mmol) was treated with Boc2O (34.5 µL, 4 eq.), HOBt (20.0 mg, 4 eq.) and 
DIEA (26.4 µL, 4 eq.) in DMF for 1 h to give peptide resin S15. 
 
Acylation of Ser side chain. 
Pre-mixed Fmoc-Phe-Cl[S6] (133 mg, 10 eq.) and DIEA (129 μL, 22 eq.) in dichloromethane (833 
μL) and DMAP (0.80 mg, 0.2 eq.) were added to peptide resin S15 (0.0340 mmol). Reaction mixture 
was shaken for overnight. Reaction progress was monitored by ESI-MS after test cleavage. 
 
Introduction of fluorescein thiocarbamoyl group. 
To peptide resin (0.0340 mmol) were added FITC (32.2 mg, 2.4 eq.) and DIEA (15.0 μL, 2.5 eq.) in 
DMF (270 μL), and reaction mixture was shaken for 5 h to give FTC derivative S16. 
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Global deprotection and purification. 
Global deprotection was performed in a manner similar to that of photo-responsive model peptide 8. 
The shuttle peptide was diastereomerically purified to give peptide 14 (19%) and its diastereomer 
(8%). Analytical HPLC condition: linear gradient of solvent B in solvent A, 10 to 60% over 30 min. 
Retention time = 21.0 (14) and 21.6 (diastereomer of 14) min. Preparative HPLC condition: linear 
gradient of solvent B in solvent A, 13 to 23% over 30 min. MS (ESI, reconstructed) calc. for 
C172H281N66O34S ([M + H]+): 3849.6, found; 3849.4 (14) and 3849.4 (diastereomer of 14). 
 
[Photo-responsive Processing Reaction of Shuttle Peptide 14] 
Shuttle peptide 14 (0.10 mg, 0.026 µmol) in acetonitril (126 µL) was added to phosphate buffer 
(0.02 M, pH 7.6, 632 µL) and was irradiated by UV light (λ >365 nm) for 4 min. Resulting mixture 
was incubated at 37 °C, and reaction was monitored by analytical HPLC. Analytical HPLC 
conditions: linear gradient of solvent B in solvent A, 10 to 60% over 30 min. 15: retention time = 
12.8 min, MS (ESI, reconstructed) calc. for C91H174N49O15 ([M + H]+): 2194.7, found; 2194.9. 17: 
retention time = 28.3 min, MS (ESI, reconstructed) calc. for C74H103N16O17S ([M + H]+): 1520.8, 
found; 1521.0. S17: retention time = 24.4 min, MS (ESI, reconstructed) calc. for C74H103N16O18S 
([M + H]+): 1536.8, found; 1537.0. S18: retention time = 27.7 min, MS (ESI, reconstructed) calc. for 
C74H103N16O18 ([M + H]+): 1504.7, found; 1505.0. 
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Figure S3. HPLC profiles (a) before UV irradiation and (b) after 4 min of UV irradiation followed 
by 1.5 h of incubation at 37 °C. Peptides were detected by UV absorbance at 220 nm. (c) Structure 
of processing products. 
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[Localization Assay of Shuttle Peptide 14] 
CHO-K1 cells were seeded on an eight-well Lab-Tek-II chamber slide (Nalge Nunc International, 
Naperville, IL) at a density of 1 x 104 cells/well in Ham’s F-10 containing 10% fetal bovine serum 
(FBS). To examine the localization of the shuttle peptide, cells were incubated with shuttle peptide 
14 (10 μM) in serum free medium for 1 h. After washing three times with ice-cold 
phosphate-buffered saline (PBS) and replacement with fresh medium containing FBS, the cells were 
irradiated by UV light (>365 nm) for 4 min. After additional 1 h of incubation, the cells were fixed 
by 4% paraformaldehyde (PFA), stained with Hoechst 33258, and then examined with confocal 
fluorescent microscopy. In some experiments, leptomycin B (LMB), an inhibitor of NES-mediated 
nuclear export, was added to a final concentration of 200 nM, after UV irradiation. 
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